{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:33:51Z","timestamp":1792420431883,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00415-021-10774-5","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T19:09:33Z","timestamp":1631128173000},"page":"2080-2098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-7779","authenticated-orcid":false,"given":"Alberto","family":"Raggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Monasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Beghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Castelpietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Mondello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Giussani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Logroscino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Giulia","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Piccininni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Pupillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ronfani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Santalucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Sattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Schiavolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Toppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimie","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Feigin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"issue":"10258","key":"10774_CR1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"issue":"5","key":"10774_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459\u2013480. https:\/\/doi.org\/10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"issue":"10","key":"10774_CR3","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","volume":"5","author":"G Deuschl","year":"2020","unstructured":"Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, Bassetti CL, Vos T, Feigin VL (2020) The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Public Health 5(10):e551\u2013e567. https:\/\/doi.org\/10.1016\/S2468-2667(20)30190-0","journal-title":"Lancet Public Health"},{"issue":"1","key":"10774_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/jnnp-2019-320466","volume":"91","author":"A Raggi","year":"2020","unstructured":"Raggi A, Leonardi M (2020) Burden of brain disorders in Europe in 2017 and comparison with other non-communicable disease groups. J Neurol Neurosurg Psychiatry 91(1):104\u2013105. https:\/\/doi.org\/10.1136\/jnnp-2019-320466","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10774_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/geront\/gnv152","volume":"56","author":"P Mazzola","year":"2016","unstructured":"Mazzola P, Rimoldi SM, Rossi P, Noale M, Rea F, Facchini C, Maggi S, Corrao G, Annoni G (2016) Aging in Italy: the need for new welfare strategies in an old country. Gerontologist 56(3):383\u2013390. https:\/\/doi.org\/10.1093\/geront\/gnv152","journal-title":"Gerontologist"},{"key":"10774_CR6","unstructured":"Italian National Institute for Statistics (2011) Il futuro demografico del Paese. Previsioni regionali della popolazione residente al 2065. Statistiche report, 1\u201312. https:\/\/www.istat.it\/it\/archivio\/48875 Accessed 28 Jul 2021"},{"issue":"Suppl 1","key":"10774_CR7","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1080\/00324728.2014.963421","volume":"69","author":"DS Reher","year":"2015","unstructured":"Reher DS (2015) Baby booms, busts, and population ageing in the developed world. Popul Stud (Camb) 69(Suppl 1):S57-68. https:\/\/doi.org\/10.1080\/00324728.2014.963421","journal-title":"Popul Stud (Camb)"},{"issue":"10258","key":"10774_CR8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"GBD 2019 Demographics Collaborators","year":"2020","unstructured":"GBD 2019 Demographics Collaborators (2020) Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1160\u20131203. https:\/\/doi.org\/10.1016\/S0140-6736(20)30977-6","journal-title":"Lancet"},{"key":"10774_CR9","doi-asserted-by":"publisher","first-page":"e712","DOI":"10.1016\/S2214-109X(15)00069-8","volume":"3","author":"JA Salomon","year":"2015","unstructured":"Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar M, Speybroeck N, Murray CJ, Vos T (2015) Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health 3:e712\u2013e723. https:\/\/doi.org\/10.1016\/S2214-109X(15)00069-8","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10774_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/head.12499","volume":"55","author":"MJ Marmura","year":"2015","unstructured":"Marmura MJ, Silberstein SD, Schwedt TJ (2015) The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache 55(1):3\u201320. https:\/\/doi.org\/10.1111\/head.12499","journal-title":"Headache"},{"issue":"2","key":"10774_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13311-018-0621-8","volume":"15","author":"T Sprenger","year":"2018","unstructured":"Sprenger T, Viana M, Tassorelli C (2018) Current prophylactic medications for migraine and their potential mechanisms of action. Neurotherapeutics 15(2):313\u2013323. https:\/\/doi.org\/10.1007\/s13311-018-0621-8","journal-title":"Neurotherapeutics"},{"issue":"Suppl 1","key":"10774_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10072-017-2901-1","volume":"38","author":"F D'Onofrio","year":"2017","unstructured":"D\u2019Onofrio F, Raimo S, Spitaleri D, Casucci G, Bussone G (2017) Usefulness of nutraceuticals in migraine prophylaxis. Neurol Sci 38(Suppl 1):117\u2013120. https:\/\/doi.org\/10.1007\/s10072-017-2901-1","journal-title":"Neurol Sci"},{"issue":"4","key":"10774_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/head.13069","volume":"57","author":"F Puledda","year":"2017","unstructured":"Puledda F, Goadsby PJ (2017) An update on non-pharmacological neuromodulation for the acute and preventive treatment of migraine. Headache 57(4):685\u2013691. https:\/\/doi.org\/10.1111\/head.13069","journal-title":"Headache"},{"issue":"6","key":"10774_CR14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/head.13337","volume":"58","author":"A Raggi","year":"2018","unstructured":"Raggi A, Grignani E, Leonardi M, Andrasik F, Sansone E, Grazzi L, D\u2019Amico D (2018) Beavioral approaches for primary headaches: recent advances. Headache 58(6):913\u2013925. https:\/\/doi.org\/10.1111\/head.13337","journal-title":"Headache"},{"issue":"1","key":"10774_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s10194-021-01267-x","volume":"22","author":"R Belv\u00eds","year":"2021","unstructured":"Belv\u00eds R, Irimia P, Pozo-Rosich P, Gonz\u00e1lez-Oria C, Cano A, Viguera J, S\u00e1nchez B, Molina F, Beltr\u00e1n I, Oterino A, Cuadrado E, G\u00f3mez-Camello A, Alberte-Woodward M, Jurado C, Oms T, Ezpeleta D, de Ter\u00e1n JD, Moroll\u00f3n N, Latorre G, Torres-Ferr\u00fas M, Alpuente A, Lamas R, Toledano C, Leira R, Santos S, Del R\u00edo MS (2021) MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention. J Headache Pain 22(1):74. https:\/\/doi.org\/10.1186\/s10194-021-01267-x","journal-title":"J Headache Pain"},{"issue":"1","key":"10774_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s10194-021-01279-7","volume":"22","author":"M Ashina","year":"2021","unstructured":"Ashina M, Cohen JM, Galic M, Campos VR, Barash S, Ning X, Kessler Y, Janka L, Diener HC (2021) Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2\u20134 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study. J Headache Pain 22(1):68. https:\/\/doi.org\/10.1186\/s10194-021-01279-7","journal-title":"J Headache Pain"},{"issue":"1","key":"10774_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-021-01247-1","volume":"22","author":"F Vernieri","year":"2021","unstructured":"Vernieri F, Altamura C, Brunelli N, Costa CM, Aurilia C, Egeo G, Fofi L, Favoni V, Pierangeli G, Lovati C, Aguggia M, d\u2019Onofrio F, Doretti A, Di Fiore P, Finocchi C, Rao R, Bono F, Ranieri A, Albanese M, Cevoli S, Barbanti P, GARLIT Study Group (2021) Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study). J Headache Pain 22(1):35. https:\/\/doi.org\/10.1186\/s10194-021-01247-1","journal-title":"J Headache Pain"},{"issue":"1","key":"10774_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-021-02123-w","volume":"21","author":"D Kudrow","year":"2021","unstructured":"Kudrow D, Cady RK, Allan B, Pederson SM, Hirman J, Mehta LR, Schaeffler BA (2021) Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial. BMC Neurol 21(1):126. https:\/\/doi.org\/10.1186\/s12883-021-02123-w","journal-title":"BMC Neurol"},{"issue":"1","key":"10774_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s10194-020-01214-2","volume":"22","author":"J Talbot","year":"2021","unstructured":"Talbot J, Stuckey R, Crawford L, Weatherby S, Mullin S (2021) Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment - real world outcomes. J Headache Pain 22(1):5. https:\/\/doi.org\/10.1186\/s10194-020-01214-2","journal-title":"J Headache Pain"},{"issue":"8","key":"10774_CR20","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/jwh.2018.7274","volume":"27","author":"RA Schroeder","year":"2018","unstructured":"Schroeder RA, Brandes J, Buse DC, Calhoun A, Eikermann-Haerter K, Golden K, Halker R, Kempner J, Maleki N, Moriarty M, Pavlovic J, Shapiro RE, Starling A, Young WB, Nebel RA (2018) Sex and gender differences in migraine-evaluating knowledge gaps. J Womens Health (Larchmt) 27(8):965\u2013973. https:\/\/doi.org\/10.1089\/jwh.2018.7274","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"10774_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s10194-019-0993-0","volume":"20","author":"M Leonardi","year":"2019","unstructured":"Leonardi M, Raggi A (2019) A narrative review on the burden of migraine: when the burden is the impact on people\u2019s life. J Headache Pain 20(1):41. https:\/\/doi.org\/10.1186\/s10194-019-0993-0","journal-title":"J Headache Pain"},{"key":"10774_CR22","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"GBD","year":"2016","unstructured":"GBD (2016) Headache Collaborators (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:954\u2013976. https:\/\/doi.org\/10.1016\/S1474-4422(18)30322-3","journal-title":"Lancet Neurol"},{"issue":"1","key":"10774_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/head.13679","volume":"60","author":"E Rota","year":"2020","unstructured":"Rota E, Zucco R, Guerzoni S, Cainazzo MM, Pini LA, Catarci T, Granella F (2020) Migraine awareness in Italy and the myth of \u201ccervical arthrosis.\u201d Headache 60(1):81\u201389. https:\/\/doi.org\/10.1111\/head.13679","journal-title":"Headache"},{"issue":"12","key":"10774_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1468-2982.2009.01874.x","volume":"29","author":"S Cevoli","year":"2009","unstructured":"Cevoli S, D\u2019Amico D, Martelletti P, Valguarnera F, Del Bene E, De Simone R, Sarchielli P, Narbone M, Testa L, Genco S, Bussone G, Cortelli P (2009) Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cephalalgia 29(12):1285\u20131293. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01874.x","journal-title":"Cephalalgia"},{"key":"10774_CR25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra1004418","volume":"365","author":"P Kwan","year":"2011","unstructured":"Kwan P, Schachter SC, Brodie MJ (2011) Drug-resistant epilepsy. N Engl J Med 365:919\u2013926. https:\/\/doi.org\/10.1056\/NEJMra1004418","journal-title":"N Engl J Med"},{"issue":"2","key":"10774_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/epi.13964","volume":"59","author":"MCH Li","year":"2018","unstructured":"Li MCH, Cook MJ (2018) Deep brain stimulation for drug-resistant epilepsy. Epilepsia 59(2):273\u2013290. https:\/\/doi.org\/10.1111\/epi.13964","journal-title":"Epilepsia"},{"key":"10774_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(18)30454-X","volume":"18","author":"GBD 2016 Epilepsy Collaborators","year":"2019","unstructured":"GBD 2016 Epilepsy Collaborators (2019) Global, regional, and national burden of epilepsy, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:357\u2013735. https:\/\/doi.org\/10.1016\/S1474-4422(18)30454-X","journal-title":"Lancet Neurol"},{"issue":"2","key":"10774_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. https:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"issue":"8","key":"10774_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1136\/jnnp-2016-315238","volume":"88","author":"HMB Lunde","year":"2017","unstructured":"Lunde HMB, Assmus J, Myhr KM, B\u00f8 L, Grytten N (2017) Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study. J Neurol Neurosurg Psychiatry 88(8):621\u2013625. https:\/\/doi.org\/10.1136\/jnnp-2016-315238","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10774_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jnnp-2011-300616","volume":"83","author":"E Kingwell","year":"2012","unstructured":"Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J, Tremlett H (2012) Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada. J Neurol Neurosurg Psychiatry 83(1):61\u201366. https:\/\/doi.org\/10.1136\/jnnp-2011-300616","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10774_CR31","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1468-1331.2009.02814.x","volume":"17","author":"P Ragonese","year":"2010","unstructured":"Ragonese P, Aridon P, Mazzola MA, Callari G, Palmeri B, Famoso G, Terruso V, Salemi G, D\u2019Amelio M, Savettieri G (2010) Multiple sclerosis survival: a population-based study in Sicily. Eur J Neurol 17(3):391\u2013397. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02814.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"10774_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/biom.12002","volume":"69","author":"M Mandel","year":"2013","unstructured":"Mandel M, Mercier F, Eckert B, Chin P, Betensky RA (2013) Estimating time to disease progression comparing transition models and survival methods\u2014an analysis of multiple sclerosis data. Biometrics 69(1):225\u2013234. https:\/\/doi.org\/10.1111\/biom.12002","journal-title":"Biometrics"},{"issue":"5","key":"10774_CR33","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1212\/WNL.0000000000011242","volume":"96","author":"T Kalincik","year":"2021","unstructured":"Kalincik T, Diouf I, Sharmin S, Malpas C, Spelman T, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Jokubaitis V, van der Walt A, Grand\u2019Maison F, Sola P, Ferraro D, Shaygannejad V, Alroughani R, Hupperts R, Terzi M, Boz C, Lechner-Scott J, Pucci E, Van Pesch V, Granella F, Bergamaschi R, Spitaleri D, Slee M, Vucic S, Ampapa R, McCombe P, Ramo-Tello C, Prevost J, Olascoaga J, Cristiano E, Barnett M, Saladino ML, Sanchez-Menoyo JL, Hodgkinson S, Rozsa C, Hughes S, Moore F, Shaw C, Butler E, Skibina O, Gray O, Kermode A, Csepany T, Singhal B, Shuey N, Piroska I, Taylor B, Simo M, Sirbu CA, Sas A, Butzkueven H, MSBase Study Group (2021) effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years. Neurology 96(5):e783\u2013e797. https:\/\/doi.org\/10.1212\/WNL.0000000000011242","journal-title":"Neurology"},{"issue":"2","key":"10774_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/jama.2018.20588","volume":"321","author":"JWL Brown","year":"2019","unstructured":"Brown JWL, Coles A, Horakova D, Havrdova E, Izquierdo G, Prat A, Girard M, Duquette P, Trojano M, Lugaresi A, Bergamaschi R, Grammond P, Alroughani R, Hupperts R, McCombe P, Van Pesch V, Sola P, Ferraro D, Grand\u2019Maison F, Terzi M, Lechner-Scott J, Flechter S, Slee M, Shaygannejad V, Pucci E, Granella F, Jokubaitis V, Willis M, Rice C, Scolding N, Wilkins A, Pearson OR, Ziemssen T, Hutchinson M, Harding K, Jones J, McGuigan C, Butzkueven H, Kalincik T, Robertson N, MSBase Study Group (2019) Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis. JAMA 321(2):175\u2013187. https:\/\/doi.org\/10.1001\/jama.2018.20588","journal-title":"JAMA"},{"issue":"6","key":"10774_CR35","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2217\/whe.10.69","volume":"6","author":"C Jobin","year":"2010","unstructured":"Jobin C, Larochelle C, Parpal H, Coyle PK, Duquette P (2010) Gender issues in multiple sclerosis: an update. Womens Health (Lond) 6(6):797\u2013820. https:\/\/doi.org\/10.2217\/whe.10.69","journal-title":"Womens Health (Lond)"},{"issue":"1","key":"10774_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10072-018-3610-0","volume":"40","author":"M Trojano","year":"2019","unstructured":"Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA, Italian Multiple Sclerosis Register Centers Group (2019) The Italian Multiple Sclerosis Register. Neurol Sci 40(1):155\u2013165. https:\/\/doi.org\/10.1007\/s10072-018-3610-0","journal-title":"Neurol Sci"},{"issue":"10113","key":"10774_CR37","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","volume":"390","author":"G Livingston","year":"2017","unstructured":"Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC, Larson EB, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selb\u00e6k G, Teri L, Mukadam N (2017) Dementia prevention, intervention, and care. Lancet 390(10113):2673\u20132734. https:\/\/doi.org\/10.1016\/S0140-6736(17)31363-6","journal-title":"Lancet"},{"key":"10774_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1474-4422(18)30468-X","volume":"18","author":"GBD 2016 Brain and Other CNS Cancer Collaborators","year":"2019","unstructured":"GBD 2016 Brain and Other CNS Cancer Collaborators (2019) Global, regional, and national burden of brain and other CNS cancer, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:376\u2013393. https:\/\/doi.org\/10.1016\/S1474-4422(18)30468-X","journal-title":"Lancet Neurol"},{"key":"10774_CR39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","volume":"17","author":"GBD 2016 Motor Neuron Disease Collaborators","year":"2016","unstructured":"GBD 2016 Motor Neuron Disease Collaborators (2016) Global, regional, and national burden of motor neuron diseases 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:1083\u20131097. https:\/\/doi.org\/10.1016\/S1474-4422(18)30404-6","journal-title":"Lancet Neurol"},{"key":"10774_CR40","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, Bonaventure A, Valkov M, Johnson CJ, Est\u00e8ve J, Ogunbiyi OJ, Azevedo-E-Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP, CONCORD Working Group (2018) Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023\u20131075. https:\/\/doi.org\/10.1016\/S0140-6736(17)33326-3","journal-title":"Lancet"},{"issue":"12","key":"10774_CR41","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s10072-013-1345-5","volume":"34","author":"P Ferroli","year":"2013","unstructured":"Ferroli P, Schiariti M, Finocchiaro G, Salmaggi A, Castiglione M, Acerbi F, Tringali G, Farinotti M, Broggi M, Roberto C, Maccagnano E, Broggi G (2013) Operability of glioblastomas: \u201csins of action\u201d versus \u201csins of non-action.\u201d Neurol Sci 34(12):2107\u20132116. https:\/\/doi.org\/10.1007\/s10072-013-1345-5","journal-title":"Neurol Sci"},{"issue":"3\u20134","key":"10774_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10072-013-1345-5","volume":"15","author":"N Sheers","year":"2014","unstructured":"Sheers N, Berlowitz DJ, Rautela L, Batchelder I, Hopkinson K, Howard ME (2014) Improved survival with an ambulatory model of non-invasive ventilation implementation in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 15(3\u20134):180\u2013184. https:\/\/doi.org\/10.1007\/s10072-013-1345-5","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"9","key":"10774_CR43","first-page":"A02200100","volume":"67","author":"SS Albrechtsen","year":"2020","unstructured":"Albrechtsen SS, Born AP, Boesen MS (2020) Nusinersen treatment of spinal muscular atrophy - a systematic review. Dan Med J 67(9):A02200100","journal-title":"Dan Med J"},{"key":"10774_CR44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GB D 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GB D 2016 Parkinson\u2019s Disease Collaborators (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"10774_CR45","unstructured":"Sabatino M (2016) The de-industrialization process in South Italy and the new industrial policies in Europe. European Regional Science Association (ERSA) 2016 conference papers ersa16p885. https:\/\/ideas.repec.org\/p\/wiw\/wiwrsa\/ersa16p885.html Accessed 28 Jul 2021"},{"issue":"3","key":"10774_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0037-1603685","volume":"37","author":"VA Hill","year":"2017","unstructured":"Hill VA, Towfighi A (2017) Modifiable risk factors for stroke and strategies for stroke prevention. Semin Neurol 37(3):237\u2013258. https:\/\/doi.org\/10.1055\/s-0037-1603685","journal-title":"Semin Neurol"},{"issue":"4","key":"10774_CR47","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/eurpub\/ckw262","volume":"27","author":"A Coppo","year":"2017","unstructured":"Coppo A, Baldissera S, Migliardi A, Minardi V, Quarchioni E, Ferrante G, Dal Molin A, Faggiano F, PASSI Working Group (2017) Quit attempts and smoking cessation in Italian adults (25\u201364 years): factors associated with attempts and successes. Eur J Public Health 27(4):717\u2013722. https:\/\/doi.org\/10.1093\/eurpub\/ckw262","journal-title":"Eur J Public Health"},{"issue":"7","key":"10774_CR48","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/nu9070734","volume":"9","author":"A Leone","year":"2017","unstructured":"Leone A, Battezzati A, De Amicis R, De Carlo G, Bertoli S (2017) Trends of adherence to the Mediterranean dietary pattern in northern Italy from 2010 to 2016. Nutrients 9(7):734. https:\/\/doi.org\/10.3390\/nu9070734","journal-title":"Nutrients"},{"key":"10774_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/BF02337162","volume":"9","author":"F Servadei","year":"1988","unstructured":"Servadei F, Ciucci G, Piazza G, Bianchedi G, Rebucci G, Gaist G, Taggi F (1988) A prospective clinical and epidemiological study of head injuries in Northern Italy: the Commune of Ravenna. Ital J Neurol Sci 9:449\u2013457","journal-title":"Ital J Neurol Sci"},{"key":"10774_CR50","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1023\/a:1026192020963","volume":"18","author":"V Baldo","year":"2003","unstructured":"Baldo V, Marcolongo A, Floreani A, Majori S, Cristofoletti M, Dal Zotto A, Vazzoler G, Trivello R (2003) Epidemiological aspect of traumatic brain injury in Northeast Italy. Eur J Epidemiol 18:1059\u20131063. https:\/\/doi.org\/10.1023\/a:1026192020963","journal-title":"Eur J Epidemiol"},{"key":"10774_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000170084","volume":"32","author":"SL Barker-Collo","year":"2009","unstructured":"Barker-Collo SL, Feigin VL (2009) Capturing the spectrum: suggested standards for conducting population-based traumatic brain injury incidence studies. Neuroepidemiology 32:1\u20133. https:\/\/doi.org\/10.1159\/000170084","journal-title":"Neuroepidemiology"},{"key":"10774_CR52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000448403","volume":"47","author":"S Barker-Collo","year":"2016","unstructured":"Barker-Collo S, Theadom A, Jones K, Feigin VL, Kahan M (2016) Accuracy of an International Classification of Diseases code surveillance system in the identification of traumatic brain injury. Neuroepidemiology 47:46\u201352. https:\/\/doi.org\/10.1159\/000448403","journal-title":"Neuroepidemiology"},{"issue":"12","key":"10774_CR53","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/sc.2017.88","volume":"55","author":"S Ferro","year":"2017","unstructured":"Ferro S, Cecconi L, Bonavita J, Pagliacci MC, Biggeri A, Franceschini M (2017) Incidence of traumatic spinal cord injury in Italy during 2013\u20132014: a population-based study. Spinal Cord 55(12):1103\u20131107. https:\/\/doi.org\/10.1038\/sc.2017.88","journal-title":"Spinal Cord"},{"issue":"1","key":"10774_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1474-4422(18)30415-0","volume":"18","author":"GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators","year":"2019","unstructured":"GBD 2016 Traumatic Brain Injury and Spinal Cord Injury Collaborators (2019) Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(1):56\u201387. https:\/\/doi.org\/10.1016\/S1474-4422(18)30415-0","journal-title":"Lancet Neurol"},{"issue":"12","key":"10774_CR55","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1474-4422(18)30387-9","volume":"17","author":"GBD 2016 Meningitis Collaborators","year":"2018","unstructured":"GBD 2016 Meningitis Collaborators (2018) Global, regional, and national burden of meningitis, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(12):1061\u20131082. https:\/\/doi.org\/10.1016\/S1474-4422(18)30387-9","journal-title":"Lancet Neurol"},{"key":"10774_CR56","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"GB D 2015 Neurological Disorders Collaborator Group","year":"2017","unstructured":"GB D 2015 Neurological Disorders Collaborator Group (2017) Global, regional, and national burden of neurological disorders during 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16:877\u2013897. https:\/\/doi.org\/10.1016\/S1474-4422(17)30299-5","journal-title":"Lancet Neurol"},{"key":"10774_CR57","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators","year":"2017","unstructured":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2","journal-title":"Lancet"},{"issue":"18","key":"10774_CR58","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","volume":"72","author":"A Alshekhlee","year":"2009","unstructured":"Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ (2009) Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 72(18):1548\u20131554. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a41211","journal-title":"Neurology"},{"issue":"8","key":"10774_CR59","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00134-013-2960-6","volume":"39","author":"MS Damian","year":"2013","unstructured":"Damian MS, Ben-Shlomo Y, Howard R, Bellotti T, Harrison D, Griggs K, Rowan K (2013) The effect of secular trends and specialist neurocritical care on mortality for patients with intracerebral haemorrhage, myasthenia gravis and Guillain-Barr\u00e9 syndrome admitted to critical care: an analysis of the Intensive Care National Audit and Research Centre (ICNARC) national United Kingdom database. Intensive Care Med 39(8):1405\u20131412. https:\/\/doi.org\/10.1007\/s00134-013-2960-6","journal-title":"Intensive Care Med"},{"issue":"11","key":"10774_CR60","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3109\/00207454.2015.1090437","volume":"126","author":"E Ruiz","year":"2016","unstructured":"Ruiz E, Ramalle-G\u00f3mara E, Qui\u00f1ones C, Mart\u00ednez-Ochoa E (2016) Trends in Guillain\u2013Barr\u00e9 syndrome mortality in Spain from 1999 to 2013. Int J Neurosci 126(11):985\u2013988. https:\/\/doi.org\/10.3109\/00207454.2015.1090437","journal-title":"Int J Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10774-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10774-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10774-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T16:11:02Z","timestamp":1647965462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10774-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10774"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10774-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"1 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"E. Beghi reports grants from UCB-Pharma, SOBI, Revalesio, the American ALS Association and the Italian Ministry of Health, outside the submitted work. M. Piccininni reports being partially funded by a research grant from Novartis Pharma for a self-initiated research project on migraine remission, and being awarded a research grant from the Center for Stroke Research Berlin (private donations). The remaining authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}